NA
IDXX icon

NewEdge Advisors’s Idexx Laboratories IDXX Stock Holding History

NewEdge Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.78M Sell
14,787
-434
-3% -$243K 0.02% 585
2026
Q1 		$8.55M Buy
15,221
+5,761
+61% +$3.69M 0.03% 495
2025
Q4 		$6.4M Buy
9,460
+6,780
+253% +$4.62M 0.02% 570
2025
Q3 		$1.71M Buy
2,680
+28
+1% +$17K 0.01% 1097
2025
Q2 		$1.42M Sell
2,652
-153
-5% -$73.2K 0.01% 1096
2025
Q1 		$1.18M Sell
2,805
-8,673
-76% -$3.77M 0.01% 1101
2024
Q4 		$4.75M Buy
11,478
+530
+5% +$232K 0.03% 516
2024
Q3 		$5.53M Buy
10,948
+1,548
+16% +$752K 0.04% 433
2024
Q2 		$4.58M Buy
9,400
+2,506
+36% +$1.26M 0.03% 476
2024
Q1 		$3.72M Buy
6,894
+670
+11% +$366K 0.03% 483
2023
Q4 		$3.43M Buy
6,224
+1,120
+22% +$526K 0.03% 462
2023
Q3 		$2.23M Buy
5,104
+1,114
+28% +$556K 0.02% 565
2023
Q2 		$2M Buy
3,990
+167
+4% +$80K 0.02% 589
2023
Q1 		$1.91M Buy
3,823
+2,116
+124% +$1.01M 0.02% 555
2022
Q4 		$346K Sell
1,707
-4,740
-74% -$1.84M 0.01% 938
2022
Q3 		$2.1M Buy
6,447
+647
+11% +$238K 0.03% 413
2022
Q2 		$2.03M Buy
+5,800
New +$2.37M 0.03% 432
2022
Q1 		– Sell
-5,123
Closed -$3.37M – 1366
2021
Q4 		$3.37M Buy
5,123
+185
+4% +$116K 0.05% 316
2021
Q3 		$3.07M Buy
4,938
+1,715
+53% +$1.15M 0.08% 239
2021
Q2 		$2.04M Buy
3,223
+400
+14% +$221K 0.05% 311
2021
Q1 		$1.38M Buy
2,823
+351
+14% +$176K 0.04% 369
2020
Q4 		$1.24M Buy
2,472
+658
+36% +$294K 0.04% 367
2020
Q3 		$713K Buy
1,814
+537
+42% +$199K 0.02% 470
2020
Q2 		$422K Buy
+1,277
New +$370K 0.02% 585
2017
Q3 		– Sell
-55
Closed -$8.88K – 709
2017
Q2 		$8.88K Buy
+55
New +$8.93K ﹤0.01% 1008

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

NewEdge Advisors's IDXX Position: Q2 2026 in Review

NewEdge Advisors reduced its Idexx Laboratories (IDXX) stake by 2.9% in Q2 2026, selling an estimated $243K and leaving 14,787 shares worth $7.78M. The position accounts for 0.02% of the portfolio, ranked #585.

NewEdge Advisors first reported a position in IDXX in Q2 2017 and has held it in 25 quarters since. The position peaked at $8.55M in Q1 2026. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • NewEdge Advisors held 14,787 shares of Idexx Laboratories worth $7.78M as of Q2 2026.
  • NewEdge Advisors sold 434 Idexx Laboratories shares in Q2 2026, an estimated $243K.
  • Idexx Laboratories made up 0.02% of NewEdge Advisors's portfolio in Q2 2026, its #585 holding.
  • NewEdge Advisors first reported a position in Idexx Laboratories in Q2 2017 and has held it in 25 quarters since.
  • NewEdge Advisors's Idexx Laboratories position peaked at $8.55M in Q1 2026.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.